Trial Information

Summary: A comparison of rosuvastatin vs. atorvastatin on atherosclerosis as measured by intravascular ultrasound

A 104-week study comparing the effects of treatment with rosuvastatin 40 mg or atrovastatin 80mg on atherosclerotic disease as measured by intravascular ultrasound.

Patient must have an upcoming clinically indicated cardiac catheterization.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:46:05 AM